Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 16,803 | 13,697 | 14,785 | 17,715 | 16,484 |
| Operating Income | -16,803 | -13,697 | -14,785 | -17,715 | -16,484 |
| Interest Expense | 491 | 461 | 417 | 410 | 406 |
| Other Income | 1,679 | 1,255 | 648 | 344 | 101 |
| Pre-tax Income | -15,616 | -12,902 | -14,553 | -17,781 | -16,788 |
| Net Income Continuous | -15,616 | -12,902 | -14,553 | -17,781 | -16,788 |
| Net Income | $-15,616 | $-12,902 | $-14,553 | $-17,781 | $-16,788 |
| EPS Basic Total Ops | -0.27 | -0.22 | -0.25 | -0.30 | -0.29 |
| EPS Basic Continuous Ops | -0.27 | -0.22 | -0.25 | -0.31 | -0.29 |
| EPS Diluted Total Ops | -0.27 | -0.22 | -0.25 | -0.30 | -0.29 |
| EPS Diluted Continuous Ops | -0.27 | -0.22 | -0.25 | -0.31 | -0.29 |
| EBITDA(a) | $-16,751 | $-13,651 | $-14,737 | $-17,656 | $-16,424 |